A shortage and user error are being blamed for a massive spike in calls to the Utah Poison Control Center over weight loss ...

Page Six exclusively spoke with a registered dietitian about the safety and efficiency of the “Kardashians” star’s latest ...

A woman who used Wegovy and Ozempic says the drugmaker didn't adequately warn her, or other patients, of serious side effects ...

You don't often see a "science day" in a Philadelphia courtroom. But that's exactly what happened last week in a potentially ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn’t ...

Kylie Jenner Annoyed by Ozempic Rumors After She's Accused of Using 'Drugs' to Lose Weight: 'Does Everyone Forget I Had 2 Children?' ...

Plus: GLP-1 drugs like Ozempic have potential to treat cancer, COVID-19, heart disease, and many other diseases.

A new study conducted by professional services firm Aon found employer health care expenditures are projected to surge 9% in 2025 to more than $16,000 per employee, markedly higher than the 6.5% ...

Analysts believe Hims & Hers will earn $0.57 per share this year and $0.80 next year. That prices the stock at 17 times next ...

Ozempic and Wegovy (semaglutide) promoted the loss of 10% or more body weight in 61% of people being treated for obesity and ...

The CEO of Novo Nordisk is defending the high cost of Ozempic and Wegovy in America, saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs.

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic ...